Possible transfer of plasmid mediated third generation cephalosporin resistance between Escherichia coli and Shigella sonnei in the human gut

Infection, Genetics and Evolution

Volumn 30, Issue , 2015, Pages 15-18

  Rashid, Harunur ^a,b   Rahman, Mahbubur ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

ESBL; Escherichia coli; MDR; R plasmid; Shigella sonnei; Third generation cephalosporin

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; AZTREONAM; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; MECILLINAM; MOXIFLOXACIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI K 12; FECES ANALYSIS; NONHUMAN; PHENOTYPE; SHIGELLA SONNEI; SHIGELLOSIS; DISK DIFFUSION; DRUG EFFECTS; ESCHERICHIA COLI; FECES; GASTROINTESTINAL TRACT; HORIZONTAL GENE TRANSFER; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PLASMID;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SHIGELLA SONNEI;

CEPHALOSPORIN RESISTANCE; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; ESCHERICHIA COLI; FECES; GASTROINTESTINAL TRACT; GENE TRANSFER, HORIZONTAL; HUMANS; PHENOTYPE; PLASMIDS; SHIGELLA SONNEI;

EID: 84917691266     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.11.023     Document Type: Article

References (20)

1. Ahmed J., Kundu M. Molecular characterization of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrob. Agents Chemother. 1999, 43:2081-2083.
2. Anderson E.S. Viability of and transfer of a plasmid from E. coli K-12 in human intestine. Nature 1975, 255:502-504.
3. Anderson J.D. Factor that may transfer of antibiotic resistance between gram-negative bacteria in the gut. J. Med. Microbiol. 1975, 8:83-88.
4. Bhattacharya S.K., Sarkar K., Nair G.B., Faruque A.S., Sack D.A. Multidrug-resistant Shigella dysenteriae type 1 in south Asia. Lancet Infect. Dis. 2003, 3:755.
5. Bradford P.A. Extended spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistant threat. Clin. Microbiol. Rev. 2001, 14:933-951.
6. Clinical Laboratory Standards Institute, 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement, Wayne, PA.
7. Fortineau N., Naas T., Gaillot O., Nordmann P. SHV-type extended spectrum β-lactamase in a Shigella sonnei clinical isolate. J. Antimicrob. Chemother. 2001, 47:685-688.
8. Neu H.C., Cherubin C.E., Longo E.D., Flouton B., Winter J. Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the Northeastern United States: a comparison of human and animal isolates. J. Infect. Dis. 1975, 132:617-622.
9. Pai H., Choi E.H., Lee H.J., Hong J.Y., Jacoby G. Identification of CTX-M-14 extended spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J. Clin. Microbiol. 1960, 39:3747-3749.
10. Portnoy D.A., Mosley S.L., Falkow S. Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 1981, 31:775-782.
11. Prats G., Mirelis B., Llovet T., Muñoz C., Miro E., Navarro F. Antibiotics resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob. Agents Chemother. 2000, 44:1140-1145.
12. Radice M., Gonzales C., Power P., Vidal M.d., Gutkind G. Third generation cephalosporin resistant in Shigella sonnei. Argentina Emerg. Infect. Dis. 2001, 7:442-443.
13. Rahman M., Shoma S., Rashid H., El Arifeen S., Baqui A.H., Siddique A.K., Nair G.B., Sack D.A. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J. Health Popul. Nutr. 2007, 25:158-167.
14. Rahman M., Shoma S., Rashid H., Siddiue A.K., Nair G.B., Sack D.A. Extended spectrum β-lactamase mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J. Antimicrob. Chemother. 2004, 54:846-847.
15. Replogle M.L., Fleming D.W., Cieslak P.R. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin. Infect. Dis. 2000, 30:515-519.
16. Salzman T.C., Klemm L. Transfer of antibiotic resistance (R factor) in the mouse intestine. Proc. Soc. Exp. Biol. Med. 1968, 128:392-394.
17. Smith H.W. Transfer of antibiotic resistance from animal and human strains of E. coli to resident E. coli in the alimentary tract of man. Lancet 1969, I:1174-1176.
18. Tenover F.C. Mechanism of antimicrobial resistance in bacteria. Am. J. Med. 2006, 199(S1):S3-S10.
19. Vercauteren E., Descheemaeker P., Ieven M., Sanders Cc., Goossens H. Comparison of screening methods for detection of extended spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian Teaching Hospital. J. Clin. Microbiol. 1997, 35:2191-2197.
20. Walton J.R. In vivo transfer of infectious drug resistance. Nature 1966, 211:312-313.